Companies hoard COVID-19 vaccines, stalling future research.
Where this comes from
- Record sourced from PubMed, PMID 37289896.
- Also identified by DOI 10.1126/science.adj1033.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Developing better products requires comparisons with existing shots that Pfizer and Moderna won't allow.
Medical subject headings
- COVID-19
- COVID-19 Vaccines
- Vaccine Development
- Animal Experimentation